Exousia Bio, Inc.

Exousia Bio, Inc.

LMMY - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$202.85K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Exousia Bio, Inc.Exousia Bio, Inc.-0.7--1%--

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$202,854.00
Enterprise Value$202,854.00
Earnings per Share$0.01
Beta-8.36
Outstanding Shares16,764,767

Return

Return on Equity-0.72%ROE
Return on Assets-0.71%
Return on Invested Capital-1.92%

Valuation & Multiples

P/E Ratio-0.69P/E Ratio
PEG0.53PEG
Price to Sales-Price to Sales
Price to Book Ratio0.01Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-0.48
Enterprise Value to Net Income-2
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Exousia Bio, Inc.

2 employees
CEO: Matthew Dwyer

Exousia Bio, Inc. is a biotechnology company that designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company's...